More nations rejecting US and UK coronavirus vaccines
A growing number of nations have rejected to use coronavirus vaccines produced in the US and UK after studies showing that they’re not effective in preventing the COVID-19 illness.
South Africa said Sunday it would suspend the start of its Covid-19 vaccinations with Britian’s AstraZeneca vaccine after a study showed "disappointing" results against its new Covid variant.
Preliminary data from a small study suggested that the AstraZeneca vaccine offers only “minimal protection against mild-moderate disease" caused by the variant in South Africa.
India has also turned down US pharmaceutical major Pfizer's application for emergency use authorization for its vaccine candidate, citing a lack of immunogenicity trials.
India has insisted on having a safety and immunogenicity trial in the country. This became an important consideration for the expert panel, which noted that there had been several serious adverse events in the case of the Pfizer vaccine and the causality of these events was being investigated.
Last month, the Leader of the Islamic Revolution Ayatollah Seyyed Ali Khamenei banned the purchase of coronavirus vaccines produced by the United States and Britain.
“Had the Americans managed to produce a vaccine, they would not have faced such a mess today in their own country. In one day, some 4,000 people died from COVID-19 in the US," Ayatollah Khamenei stated in JAnuary, adding, "I really don't trust them. Sometimes they want to test the vaccine on other nations."
The US has experienced more deaths and infections from the coronavirus than any other nation in the world.
Even inside the US, many Americans are skeptical about the safety of coronavirus vaccines. A recent Pew Research Center survey found that only 72% of Americans would probably or definitely get a coronavirus vaccine if it were available.
In Germany, there was an outbreak of the UK variant of coronavirus at a nursing home in Belm. The outbreak came despite all of its residents already receiving two doses of the BioNTech-Pfizer vaccine, with their last shot on January 25.